Milestone Pharmaceuticals (MIST) Non-Current Assets (2018 - 2026)

Milestone Pharmaceuticals (MIST) has reported Non-Current Assets for 9 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets rose 3.92% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2026 stood at $5.5 million (down 7.55% YoY), and the FY2025 full-year result was $1.6 million, up 4.26% from the prior year.
• Non-Current Assets declined to $1.3 million in Q2 2026 per MIST's latest filing, from $1.5 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $2.8 million in Q3 2022 and bottomed at $797000.0 in Q2 2022.
• Historically, Non-Current Assets has averaged $1.8 million across 5 years, with a median of $1.7 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Non-Current Assets jumped 208.76% in 2023, then plunged 37.06% in 2025.
• Over 5 years, Non-Current Assets stood at $2.7 million in 2022, then slipped by 18.13% to $2.2 million in 2023, then fell by 28.3% to $1.6 million in 2024, then increased by 4.26% to $1.6 million in 2025, then fell by 20.85% to $1.3 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $1.3 million, $1.5 million, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.